The Magazine for Sleep Professionals
Tuesday, September 29, 2026
EnsoData, a leader in healthcare AI technology, is partnering with Advanced Brain Monitoring (ABM) to add position data captured by ABM’s Night Shift sleep positioner into the FDA-cleared EnsoSleep PPG home sleep test (HST). Adding positional data to EnsoSleep PPG offers providers accurate supine AHI severity insights, leading to better […]
The advent of home sleep tests (HSTs) has revolutionized the diagnosis and management of sleep disorders, particularly obstructive sleep apnea (OSA). As a sleep doctor, I frequently engage with colleagues and professionals within the sleep industry to discuss the nuances and complexities of interpreting HST results. This article aims to […]
Nyxoah SA has announced the DREAM U.S. pivotal study achieved a statistically significant reduction in the co-primary endpoints of 12-month AHI responder rate, per the Sher criteria, and ODI responder rate, both on an ITT basis. The DREAM study is a pivotal trial being conducted under an investigational device exemption […]
By Snorri Helgason Introduction Sleep apnea has been identified as a serious health issue for most countries. It exerts a substantial influence on individuals’ physical and mental health, impairing daily functioning and overall quality of life if left untreated. Moreover, sleep apnea imposes a substantial burden on society, leading to […]
Inspire Medical Systems, Inc. announced that it has received approval from the Food and Drug Administration (FDA) on an expanded indication. The update includes an increase on the upper limit of the Apnea-Hypopnea Index (AHI) to 100 events per hour from 65 and raises the Body Mass Index (BMI) warning […]
Incannex Healthcare Limited (‘Incannex’ or the ‘Company’) a clinical-stage pharmaceutical company developing unique medicinal cannabinoid pharmaceutical products and psychedelic medicine therapies for unmet medical needs, is pleased to announce that it has completed analysis of data from the Phase 2 proof-of-concept clinical trial investigating IHL-42X for treatment of obstructive sleep […]
Siesta Medical, Inc. announced the online publication of a recent study of the AIRLIFT procedure titled “Hyoid Suspension With UPPP for the Treatment of Obstructive Sleep Apnea” in the Ear, Nose & Throat Journal. This multicenter study evaluated the safety and efficacy of AIRLIFT hyoid suspension when combined with procedures for […]
By Lindsey Nolen A common misconception across sleep medicine is that continuous positive airway pressure (CPAP) machines fully resolve sleep-disordered breathing (SDB) in apnea patients showing a successful AHI. However, research has shown that residual SDB can still occur during the use of a CPAP machine, leading to the need […]
Signifier Medical Technologies, an innovator in the sleep-disordered breathing market announced that eXciteOSA®, the first and only daytime intraoral neuromuscular stimulation device for treating mild obstructive sleep apnea and snoring, has been cleared by the U.S. Food and Drug Administration (FDA), giving millions of sufferers in the U.S. access to […]
Nox Medical, the sleep medical device branch of Nox Health, has revolutionized home sleep testing with the launch of its newest device, the Nox T3s. The Nox T3s is based on the world-renowned Nox T3, which launched in 2009 and quickly became, for many, the standard for home sleep testing. […]
